Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Candel Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
   10-K10-KS-1
Revenues  0.10.16.6
            Revenue growth  0.0%-98.1% 
Cost of goods sold  0.00.09.2
Gross profit  0.10.1-2.6
            Gross margin  100.0%100.0%-38.7%
Selling, general and administrative   [+]25.913.92.6
Other operating expenses  8.32.53.9
EBITDA   [+]-33.8-16.2-9.0
            EBITDA margin  -27034.4%-12984.0%-136.1%
Depreciation and amortization  0.20.10.0
EBIT   [+]-34.0-16.3-9.0
            EBIT margin  -27220.0%-13056.8%-136.8%
Non-recurring items   [+]1.10.6 
Interest income  -0.10.1 
Other income (expense), net   [+]-1.0-0.80.8
Pre-tax income  -36.1-17.7-8.2
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -36.1-17.7-8.2
            Net margin  -28899.2%-14144.0%-124.7%
   
Basic EPS   [+]($1.91)($1.52) 
Diluted EPS   [+]($1.91)($1.52) 
   
Shares outstanding (basic)   [+]18.911.6 
Shares outstanding (diluted)   [+]18.911.6 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy